Can we use plasma hyperosmolality as a predictor of mortality for ST-segment elevation myocardial infarction?


Tatlisu M. A., Kaya A., Keskin M., UZMAN O., Borklu E. B., ÇİNİER G., ...Daha Fazla

Coronary Artery Disease, cilt.28, sa.1, ss.70-76, 2017 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1097/mca.0000000000000426
  • Dergi Adı: Coronary Artery Disease
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.70-76
  • Anahtar Kelimeler: mortality, plasma osmolality, primary percutaneous coronary intervention, ST-segment elevation myocardial infarction
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background The aim of this study was to investigate the association of plasma osmolality with all-cause mortality in ST-segment elevation myocardial infarction (STEMI) patients treated with a primary percutaneous coronary intervention. Methods This study included 3748 patients (mean age 58.3±11.8 years, men 81%) with STEMI treated with primary percutaneous coronary intervention. The following formula was used to measure the plasma osmolality at admission: Osmolality=1.86×sodium (mmol/l)+glucose (mg/dl)/18+BUN (mg/dl)/2.8+9. Results The patients were followed up for a mean period of 22±10 months. Patients with higher plasma osmolality had 3.7 times higher in-hospital (95% confidence interval: 2.7-5.1) and 3.2 times higher long-term (95% confidence interval: 2.5-4.1) all-cause mortality rates than patients with lower plasma osmolality. Conclusion Plasma osmolality was found to be a predictor of both in-hospital and long-term all-cause mortality. Hence, plasma osmolality can be used to detect high-risk patients in STEMI.